Figure 1
Figure 1. Synergism in the induction of Ang2 by VEGF and bFGF. (A) Dose-response curve for bFGF induction of Ang2. HUVECs were treated with constant VEGF (50 ng/mL) and increasing bFGF concentrations (0-250 ng/mL) for 20 hours. Levels of Ang2 were determined by Western blotting (α-tubulin levels are shown to indicate equal loading; n = 3). The intensity of the Ang2 bands was determined by autoradiography and densitometry as described in “Methods.” (B) Mean Ang2 levels were expressed as the percentage of control (VEGF, 50 ng/mL; bFGF, 0 ng/mL). The EC50 value for the bFGF was calculated by nonlinear regression. (C) Synergism between VEGF and bFGF (VF) in the induction of Ang2 was established at optimal conditions (VEGF, 50 ng/mL; bFGF, 20 ng/mL) by Western blotting. “+” signifies Ang2-positive control.

Synergism in the induction of Ang2 by VEGF and bFGF. (A) Dose-response curve for bFGF induction of Ang2. HUVECs were treated with constant VEGF (50 ng/mL) and increasing bFGF concentrations (0-250 ng/mL) for 20 hours. Levels of Ang2 were determined by Western blotting (α-tubulin levels are shown to indicate equal loading; n = 3). The intensity of the Ang2 bands was determined by autoradiography and densitometry as described in “Methods.” (B) Mean Ang2 levels were expressed as the percentage of control (VEGF, 50 ng/mL; bFGF, 0 ng/mL). The EC50 value for the bFGF was calculated by nonlinear regression. (C) Synergism between VEGF and bFGF (VF) in the induction of Ang2 was established at optimal conditions (VEGF, 50 ng/mL; bFGF, 20 ng/mL) by Western blotting. “+” signifies Ang2-positive control.

Close Modal

or Create an Account

Close Modal
Close Modal